Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,300 warrant series at 1,050 companies. 780 in the money, 59 expiring in the next 30 days, 37 waiting on a stockholder vote or other stated condition, 3 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Short-term loan warrants — December 13, 2024 Loan (Investor Term Sheet lenders incl. DRE Chicago) | $0.0071 | $1.0M | 424B3, May 20, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Short-term loan warrants — December 6, 2024 Loan (Endurance Antarctica Partners II) | $0.0071 | $1.0M | DEF 14A, Apr 21, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Representative's (Underwriter) Warrants from IPO | $0.3089 | $1.0M | S-3, Nov 18, 2025Dilution tabAs of Nov 3, 2026 | ||||||||
| August 2024 inducement warrants five-year ($12.00) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| August 2024 placement agent warrants ($20.10) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| July 2026 placement agent warrants ($1.775) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| July 2026 pre-funded warrants ($0.001) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| July 2026 Series F warrants ($1.42) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| July 2026 Series G warrants ($1.42) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| June 2025 placement agent warrants ($5.00) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| June 2025 Series D warrants ($4.00) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| June 2025 Series E warrants ($4.00) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| March 2024 placement agent warrants ($19.20) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| November 2023 investor warrants ($24.96) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| November 2023 placement agent warrants ($38.40) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| October 2022 warrants ($0.00) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| October 2022 warrants ($1,944.00) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| October 2022 warrants ($2,332.80) | $0.3093 | $995K | 10-Q, Oct 26, 2026Dilution tabAs of Oct 26, 2026 | ||||||||
| August 2025 PIPE Warrants and RD Placement Common Warrants (remaining after October 2025 repurchase) | $0.3951 | $995K | 10-K, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| December 2024 Inducement Common Warrants (Repriced Warrants) | $0.3951 | $995K | S-3, Jan 13, 2025Dilution tabAs of Nov 17, 2026 | ||||||||
| December 2025 RDO Common Warrants | $0.3951 | $995K | 10-K, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| June 2024 Private Placement Warrants (Armistice) — warrants issued June 18, 2024 concurrent with registered direct offering | $1.21 | $987K | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| IPO Representative's Warrants (June 2022) | $0.3802 | $968K | POS AM, Sep 28, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| IPO Warrants (June 2022, SVREW) | $0.3802 | $968K | POS AM, Sep 28, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| January 2025 Placement Agent Warrants (H.C. Wainwright designees) | $0.3802 | $968K | POS AM, Sep 28, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| January 2025 Private Placement (Investor) Warrants | $0.3802 | $968K | POS AM, Sep 28, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| Placement agent (Dawson James) warrants – June 2024 registered offering, $37.50, exp. 6/29/2029 | $0.1917 | $948K | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Placement agent (Dawson James) warrants – September 2024 registered offering, $20.70, exp. 9/4/2029 | $0.1917 | $948K | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series H Preferred Purchase Warrants (July 2, 2025 public offering), $25.00 per Series H share, exp. 7/2/2030 | $0.1917 | $948K | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Underwriter (ThinkEquity) warrants – February/March 2024 public offering, $56.25, exp. 2/27/2029 | $0.1917 | $948K | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2026 Common Warrants (Maxim best-efforts public offering) — outstanding | $0.6882 | $927K | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Other warrants — residual of 10-Q warrant table (October 2022 Warrants and other pre-May 2024 series) | $0.2800 | $923K | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Placement Agent Warrants (May 2024, H.C. Wainwright designees) | $0.2800 | $923K | 424B3, May 10, 2024Dilution tabAs of Nov 9, 2026 | ||||||||
| Series C Warrants (May 2024 warrant inducement) | $0.2800 | $923K | 424B3, May 10, 2024Dilution tabAs of Nov 9, 2026 | ||||||||
| 2025 Finder's Warrant (Pure Equity Ltd.) | $0.4610 | $910K | F-3, Aug 13, 2025Dilution tabAs of Nov 14, 2026 | ||||||||
| 2025 Private Placement Common Warrants (July 2025 Units) | $0.4610 | $910K | F-3, Aug 13, 2025Dilution tabAs of Nov 14, 2026 | ||||||||
| 2025 Private Placement Pre-Funded Warrants (unexercised remainder) | $0.4610 | $910K | F-3, Nov 10, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Additional January 2026 Warrant (Second Note Purchase Agreement) | $0.4610 | $910K | 6-K EX-99.2, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Eighth Warrant (September 2026 Warrant) | $0.4610 | $910K | 6-K EX-99.2, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| January 2026 Warrant (First Note Purchase Agreement) | $0.4610 | $910K | 6-K EX-99.2, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| November 2024 Warrants (amended August 13, 2025) | $0.4610 | $910K | F-3, Aug 13, 2025Dilution tabAs of Nov 14, 2026 | ||||||||
| November 2026 Warrant (November Note Warrants) | $0.4610 | $910K | F-3, Nov 10, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| October 2026 Convertible Settlement Warrants | $0.4610 | $910K | F-3, Oct 8, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Seventh Warrant (August 2026 Warrant) | $0.4610 | $910K | 6-K EX-99.2, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Sixth Warrant (July 2026 Warrant) | $0.4610 | $910K | 6-K EX-99.2, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2024 Warrants (April 2024 registered direct, $17.50) | $0.8399 | $908K | 10-Q, Aug 13, 2026Dilution tabAs of Oct 16, 2026 | ||||||||
| 2025 Warrants (Series C private placement, Initial and Second Closing combined) | $0.8399 | $908K | 10-Q, Aug 13, 2026Dilution tabAs of Oct 16, 2026 | ||||||||
| Pre-funded warrants (November 2026 private placement) | $0.4575 | $828K | PR, Nov 11, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Warrants outstanding — 10-Q aggregate (September 30, 2026) | $0.4575 | $828K | 10-Q, Nov 6, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| May 2022 Warrants | $0.3150 | $815K | 20-F, Apr 29, 2026Dilution tabAs of Nov 10, 2026 |
SDSTStardust Power Inc.$0.0071Last price
Short-term loan warrants — December 13, 2024 Loan (Investor Term Sheet lenders incl. DRE Chicago)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.0M
SDSTStardust Power Inc.$0.0071Last price
Short-term loan warrants — December 6, 2024 Loan (Endurance Antarctica Partners II)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.0M
TRUGTruGolf Holdings, Inc.$0.3089Last price
Representative's (Underwriter) Warrants from IPO
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.0M
BBLGBone Biologics Corporation$0.3093Last price
August 2024 inducement warrants five-year ($12.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
August 2024 placement agent warrants ($20.10)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
July 2026 placement agent warrants ($1.775)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
July 2026 pre-funded warrants ($0.001)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
July 2026 Series F warrants ($1.42)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
July 2026 Series G warrants ($1.42)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
June 2025 placement agent warrants ($5.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
June 2025 Series D warrants ($4.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
June 2025 Series E warrants ($4.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
March 2024 placement agent warrants ($19.20)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
November 2023 investor warrants ($24.96)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
November 2023 placement agent warrants ($38.40)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
October 2022 warrants ($0.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
October 2022 warrants ($1,944.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
BBLGBone Biologics Corporation$0.3093Last price
October 2022 warrants ($2,332.80)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
PWCMPowerCompute, Inc.$0.3951Last price
August 2025 PIPE Warrants and RD Placement Common Warrants (remaining after October 2025 repurchase)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
PWCMPowerCompute, Inc.$0.3951Last price
December 2024 Inducement Common Warrants (Repriced Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
PWCMPowerCompute, Inc.$0.3951Last price
December 2025 RDO Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$995K
IPWiPower Inc.$1.21Last price
June 2024 Private Placement Warrants (Armistice) — warrants issued June 18, 2024 concurrent with registered direct offering
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$987K
SVRESaverOne 2014 Ltd. American Depositary Shares$0.3802Last price
IPO Representative's Warrants (June 2022)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$968K
SVRESaverOne 2014 Ltd. American Depositary Shares$0.3802Last price
IPO Warrants (June 2022, SVREW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$968K
SVRESaverOne 2014 Ltd. American Depositary Shares$0.3802Last price
January 2025 Placement Agent Warrants (H.C. Wainwright designees)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$968K
SVRESaverOne 2014 Ltd. American Depositary Shares$0.3802Last price
January 2025 Private Placement (Investor) Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$968K
OGENOragenics, Inc.$0.1917Last price
Placement agent (Dawson James) warrants – June 2024 registered offering, $37.50, exp. 6/29/2029
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$948K
OGENOragenics, Inc.$0.1917Last price
Placement agent (Dawson James) warrants – September 2024 registered offering, $20.70, exp. 9/4/2029
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$948K
OGENOragenics, Inc.$0.1917Last price
Series H Preferred Purchase Warrants (July 2, 2025 public offering), $25.00 per Series H share, exp. 7/2/2030
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$948K
OGENOragenics, Inc.$0.1917Last price
Underwriter (ThinkEquity) warrants – February/March 2024 public offering, $56.25, exp. 2/27/2029
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$948K
IPDNProfessional Diversity Network, Inc.$0.6882Last price
August 2026 Common Warrants (Maxim best-efforts public offering) — outstanding
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$927K
ATXIAvenue Therapeutics, Inc.$0.2800Last price
Other warrants — residual of 10-Q warrant table (October 2022 Warrants and other pre-May 2024 series)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$923K
ATXIAvenue Therapeutics, Inc.$0.2800Last price
Placement Agent Warrants (May 2024, H.C. Wainwright designees)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$923K
ATXIAvenue Therapeutics, Inc.$0.2800Last price
Series C Warrants (May 2024 warrant inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$923K
IMCCIM Cannabis Corp.$0.4610Last price
2025 Finder's Warrant (Pure Equity Ltd.)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$910K
IMCCIM Cannabis Corp.$0.4610Last price
2025 Private Placement Common Warrants (July 2025 Units)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$910K
IMCCIM Cannabis Corp.$0.4610Last price
2025 Private Placement Pre-Funded Warrants (unexercised remainder)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$910K
IMCCIM Cannabis Corp.$0.4610Last price
Additional January 2026 Warrant (Second Note Purchase Agreement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$910K
IMCCIM Cannabis Corp.$0.4610Last price
Eighth Warrant (September 2026 Warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$910K
IMCCIM Cannabis Corp.$0.4610Last price
January 2026 Warrant (First Note Purchase Agreement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$910K
IMCCIM Cannabis Corp.$0.4610Last price
November 2024 Warrants (amended August 13, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$910K
IMCCIM Cannabis Corp.$0.4610Last price
November 2026 Warrant (November Note Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$910K
IMCCIM Cannabis Corp.$0.4610Last price
October 2026 Convertible Settlement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$910K
IMCCIM Cannabis Corp.$0.4610Last price
Seventh Warrant (August 2026 Warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$910K
IMCCIM Cannabis Corp.$0.4610Last price
Sixth Warrant (July 2026 Warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$910K
MTNBMatinas BioPharma Holdings, Inc.$0.8399Last price
2024 Warrants (April 2024 registered direct, $17.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$908K
MTNBMatinas BioPharma Holdings, Inc.$0.8399Last price
2025 Warrants (Series C private placement, Initial and Second Closing combined)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$908K
PTIXProtagenic Therapeutics, Inc.$0.4575Last price
Pre-funded warrants (November 2026 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$828K
PTIXProtagenic Therapeutics, Inc.$0.4575Last price
Warrants outstanding — 10-Q aggregate (September 30, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$828K
SPRCSciSparc Ltd. Ordinary Shares$0.3150Last price
May 2022 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$815K
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,061 dilution snapshots. 4,846 of 5,300 series state an exercise price and 3,366 an expiry date. 98 record when exercise begins; that count grows as companies are re-extracted. 633 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.